M E Roland

Summary

Affiliation: California Environmental Protection Agency
Country: USA

Publications

  1. pmc Preventing human immunodeficiency virus infection among sexual assault survivors in Cape Town, South Africa: an observational study
    Michelle E Roland
    Positive Health Program at San Francisco General Hospital, University of California San Francisco, 94110, USA
    AIDS Behav 16:990-8. 2012
  2. ncbi request reprint HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes
    M E Roland
    University of California, San Francisco, CA, USA
    Am J Transplant 8:355-65. 2008
  3. pmc A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV
    Michelle E Roland
    Positive Health Program, Department of Internal Medicine, San Francisco General Hospital, San Francisco, California, USA
    Clin Infect Dis 53:76-83. 2011
  4. ncbi request reprint Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study
    J O Kahn
    Positive Health Program, Dept of Medicine, University of California San Francisco, at San Francisco General Hospital, 995 Potrero Ave, San Francisco, CA 94110, USA
    J Infect Dis 183:707-14. 2001
  5. ncbi request reprint Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients
    L A Frassetto
    Department of Medicine, Clinical Research Center, University of California, San Francisco, CA, USA
    Am J Transplant 7:2816-20. 2007
  6. pmc Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients
    C S Coffin
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 10:1268-75. 2010
  7. ncbi request reprint Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients
    J T Carter
    Department of Surgery, University of California, San Francisco, California, USA
    Am J Transplant 6:753-60. 2006
  8. pmc Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients
    P G Stock
    Department of Surgery, University of California, San Francisco, CA
    Am J Transplant 14:1136-41. 2014
  9. ncbi request reprint Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure
    M E Roland
    University of California at San Francisco, Div of AIDS, Dept of Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    J Infect Dis 184:1608-12. 2001

Collaborators

Detail Information

Publications9

  1. pmc Preventing human immunodeficiency virus infection among sexual assault survivors in Cape Town, South Africa: an observational study
    Michelle E Roland
    Positive Health Program at San Francisco General Hospital, University of California San Francisco, 94110, USA
    AIDS Behav 16:990-8. 2012
    ..Adherence interventions and targeted risk reduction counseling should be provided to minimize HIV acquisition...
  2. ncbi request reprint HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes
    M E Roland
    University of California, San Francisco, CA, USA
    Am J Transplant 8:355-65. 2008
    ....
  3. pmc A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV
    Michelle E Roland
    Positive Health Program, Department of Internal Medicine, San Francisco General Hospital, San Francisco, California, USA
    Clin Infect Dis 53:76-83. 2011
    ..Intensive risk reduction and adherence counseling appear to be effective but are resource intensive. Identifying simpler interventions that maximize the HIV prevention potential of PEP is critical...
  4. ncbi request reprint Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study
    J O Kahn
    Positive Health Program, Dept of Medicine, University of California San Francisco, at San Francisco General Hospital, 995 Potrero Ave, San Francisco, CA 94110, USA
    J Infect Dis 183:707-14. 2001
    ..PEP, after nonoccupational HIV exposure, is feasible for persons at risk for HIV infection...
  5. ncbi request reprint Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients
    L A Frassetto
    Department of Medicine, Clinical Research Center, University of California, San Francisco, CA, USA
    Am J Transplant 7:2816-20. 2007
    ..Changes in antiretroviral therapy should be carefully managed to avoid insufficient immunosuppression or toxicity due to drug interactions...
  6. pmc Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients
    C S Coffin
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 10:1268-75. 2010
    ..Combination HBIG and antivirals is effective as prophylaxis with no clinical evidence of HBV recurrence but low-level HBV DNA is detectable in approximately 50% of recipients...
  7. ncbi request reprint Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients
    J T Carter
    Department of Surgery, University of California, San Francisco, California, USA
    Am J Transplant 6:753-60. 2006
    ....
  8. pmc Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients
    P G Stock
    Department of Surgery, University of California, San Francisco, CA
    Am J Transplant 14:1136-41. 2014
    ..Future studies of sirolimus as a reservoir-modifying agent are warranted...
  9. ncbi request reprint Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure
    M E Roland
    University of California at San Francisco, Div of AIDS, Dept of Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    J Infect Dis 184:1608-12. 2001
    ..The treatment history, particularly nonuse of a class of antiretroviral drugs, can be used to predict drug resistance...